Evidence map›Paper›PMID 41042119›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Long-term socioeconomic outcomes in Danish children with moderate-to-severe atopic dermatitis.

Sigrun Alba Johannesdottir Schmidt, Dóra Körmendiné Farkas, Mette S Deleuran, Christian Vestergaard, Henrik T Sørensen, Niels Skipper, Sinéad M Langan

Abstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Long-term socioeconomic outcomes in Danish children with moderate-to-severe atopic dermatitis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  3. New insights in the burden of atopic dermatitis: How holistic care also considers socio-economics.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sigrun Alba Johannesdottir SchmidtDepartment of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-5527-0698
Dóra Körmendiné FarkasDepartment of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
Mette S DeleuranDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.ORCID https://orcid.org/0000-0003-0593-9925
Christian VestergaardDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Henrik T SørensenDepartment of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0003-4299-7040
Niels SkipperDepartment of Economics and Business Economics, Aarhus University, Aarhus, Denmark.
Sinéad M LanganFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Funding

Wellcome TrustWellcome Trust 205039/Z/16/Z
6 · The paper itself

Abstract

backgroundThe long-term socioeconomic impact of atopic dermatitis (AD) is poorly understood.

objectivesTo examine if childhood AD is associated with labor market and relationship outcomes in adulthood.

methodsThis nationwide registry-based Danish cohort study included children born between 1973 and 1991: 8409 with hospital-diagnosed AD before age 18 (baseline) and 853,228 without. A sibling cohort (5119 with AD; 6352 without) was used to control for family-related confounding. The main outcomes were earned income, long-term unemployment, single partnership status and childlessness by age 30. We used linear regression for income and Poisson regression for binary outcomes, adjusted for income, sex, calendar year, comorbidities and childhood socioeconomic status.

resultsChildren with AD had slightly lower income (adjusted mean percentile difference - 1.2) and higher risk of long-term unemployment (adjusted relative risk [aRR] 1.11; 95% CI: 1.05-1.17) by age 30, though the absolute difference was <1%. AD was not associated with secondary labor market outcomes (e.g. health-related work absenteeism), except for disability pension, but the RR decreased from 1.55 to 1.15 (95% CI: 1.02-1.30) when adjusting for comorbidities. By age 30, 22.1% with AD remained single versus 19.4% without (aRR 1.11; 95% CI: 1.06-1.15), with stronger associations among males, those with severe eczema, hand/contact dermatitis or low maternal education (aRRs up to 1.41). AD was not associated with childlessness at age 30 (57.7% vs. 56.7%; aRR 1.01; 95% CI: 1.00-1.03), but a 2.5% absolute difference appeared by age 40. In the sibling analysis, most associations diminished.

conclusionsModerate-to-severe childhood AD was not linked to labor market outcomes, apart from disability pensions, likely driven by comorbidities. The probability of partnership or parenthood was reduced in specific subgroups. Confounding from family-related factors cannot be excluded. Nevertheless, the results underscore the importance of considering patients' broader life situations to support them through adulthood.

Indexed as

Dermatitis, AtopicAdolescentAdultChildChild, PreschoolCohort StudiesDenmarkEmploymentFemaleHumansIncomeInfantMaleRegistriesSeverity of Illness IndexSocioeconomic Factorsatopic dermatitiscohort studiesDenmarkemploymentepidemiologyfamilyincomeregistriessick leavesocioeconomic factors

Identifiers

PMID41042119
PMCPMC12723571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.